Use of Factor Vila or Factor Vila equivalent to prevent or reduce increased bleeding and / or edema formation after intracerebral hemorrhage (ICH) in patients treated with antiplatelet therapy

摘要

The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for preventing complications in ICH patients treated with antiplatelet therapy.